Depomed Announces the Appointment of Phillip B. Donenberg as Chief Financial Officer
"Phil brings exceptional finance experience and a proven track record of success, most recently as CFO of AveXis," said
Mr. Donenberg, 57, has extensive experience with more than 23 years of leadership in finance, mergers and acquisitions (M&A) and operations with most of his career focused in specialty pharmaceuticals and healthcare. Most recently, he served as Chief Financial Officer and Senior Vice President for
"I am extremely pleased to be joining
"On behalf of the board, our executive leadership team and all the employees at
INVESTOR AND MEDIA CONTACTS:
SVP, Investor Relations and Corporate Communications
Source: Depomed, Inc.
Minimum 15 minutes delayed.